Circulating C-reactive protein concentrations and risks of colon and rectal cancer: A nested case-control study within the European prospective investigation into cancer and nutrition

American Journal of Epidemiology

Volumn 172, Issue 4, 2010, Pages 407-418

  Aleksandrova, Krasimira ^a   Jenab, Mazda ^b   Boeing, Heiner ^a   Jansen, Eugene ^c   Bueno De Mesquita, H Bas ^c,d   Rinaldi, Sabina ^b   Riboli, Elio ^e   Overvad, Kim ^f   Dahm, Christina C ^g   Olsen, Anja ^h   Tjønneland, Anne ^h   Boutron Ruault, Marie Christine ⁱ   Clavel Chapelon, Franoise ⁱ   Morois, Sophie ⁱ   Palli, Domenico ^j   Krogh, Vittorio ^k   Tumino, Rosario ^l   Vineis, Paolo ^e,m,n   Panico, Salvatore ^o   Kaaks, Rudolf ^p   Rohrmann, Sabine ^p   Trichopoulou, Antonia ^q   Lagiou, Pagona ^q   Trichopoulos, Dimitrios ^r,s   Van Duijnhoven, Fränzel J B ^c   Leufkens, Anke M ^c,d   Peeters, Petra H ^d   Rodríguez, Laudina ^t   Bonet, Catalina ^u   Sánchez, María José ^v   Dorronsoro, Miren ^w   Navarro, Carmen ^x   Barricarte, Aurelio ^y   Palmqvist, Richard ^z   Hallmans, Göran ^z   Khaw, Kay Tee ^aa   Wareham, Nicholas ^ab   Allen, Naomi E ^ac   Spencer, Elizabeth ^ac   Romaguera, Dora ^e   Norat, Teresa ^e   Pischon, Tobias ^a   more..

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f AARHUS UNIVERSITY   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

ⁱ INSERM   (France)

^j CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l CIVILE M P AREZZO HOSPITAL   (Italy)

^m UNIVERSITY OF TURIN   (Italy)

ⁿ Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^r HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^s BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^t Health and Health Care Services Council   (Spain)

^u CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w Public Mental Health Network of Gipuzkoa Osakidetza   (Spain)

^x Murcia Regional Health Authority   (Spain)

^y INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^z UMEÅ UNIVERSITY   (Sweden)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

abdominal; C reactive protein; colorectal neoplasms; hyperglycemia; hyperinsulinism; hyperlipidemias; inflammation; obesity

Indexed keywords

C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

CANCER; EDUCATION; HEALTH RISK; HEMOGLOBIN; HORMONE; LIPID; LOGISTICS; MULTIVARIATE ANALYSIS; NONLINEARITY; OBESITY; PEPTIDE; PROTEIN; REGRESSION ANALYSIS; SMOKING;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER RISK; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDUCATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MENSTRUAL CYCLE; NUTRITIONAL ASSESSMENT; OBESITY; RECTUM CANCER; RISK ASSESSMENT; SMOKING; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; COLONIC NEOPLASMS; EUROPE; INCIDENCE; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTOR; STATISTICAL MODEL;

EUROPE;

ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COLONIC NEOPLASMS; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 77955899767     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq135     Document Type: Article

References (44)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4): 526-535.
3. Jess T, Gamborg M, Matzen P, et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100(12): 2724-2729.
4. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colo-rectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006;23(8):1097-1104.
5. Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemo-prevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101(4):256-266.
6. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6): 448-454.
7. Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004;291(5): 585-590 (Pubitemid 38500312)
8. Il'yasova D, Colbert LH, Harris TB, et al. Circulating levels of inflammatory markers and cancer risk in the Health Aging and Body Composition cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2413-2418.
9. Zhang SM, Buring JE, Lee IM, et al. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med. 2005;142(6):425-432.
10. Ito Y, Suzuki K, Tamakoshi K, et al. Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study. J Epidemiol. 2005;15(suppl 2):S185-189S.
11. Otani T, Iwasaki M, Sasazuki S, et al. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev. 2006;15(4):690-695.
12. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006;66(4):2483-2487.
13. Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24(33): 5216-5222.
14. Trichopoulos D, Psaltopoulou T, Orfanos P, et al. Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiol Biomarkers Prev. 2006;15(2): 381-384.
15. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009;27(13):2217-2224.
16. Tsilidis KK, Branchini C, Guallar E, et al. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer. 2008;23(5):1133-1140.
17. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cyto-kines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19(4):972-978.
18. Festa A, D'Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-47.
19. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920-931. (Pubitemid 44018922)
20. Jenab M, Riboli E, Cleveland RJ, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2007;121(2):368-376. (Pubitemid 46917707)
21. Rinaldi S, Rohrmann S, Jenab M, et al. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3108-3115.
22. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86(suppl 3): S836-S842.
23. Stocks T, Lukanova A, Johansson M, et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond). 2008;32(2):304-314.
24. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B): 1113-1124. (Pubitemid 36313608)
25. Riboli E, Kaaks R. The EPIC project: rationale and study design. Int J Epidemiol. 1997;26(suppl 1):6S-14S.
26. Bingham S, Riboli E. Diet and cancer\the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer. 2004;4(3):206-215.
27. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika. 1978;65(1):153-158.
28. Hsieh CC, Maisonneuve P, Boyle P, et al. Analysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects? Epidemiology. 1991;2(2):137-140.
29. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.
30. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551-561.
31. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287(1): G7-G17.
32. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101(5):403-408.
33. Friedenreich C, Norat T, Steindorf K, et al. Physical activity and risk of colon and rectal cancers: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2398-2407. (Pubitemid 46048296)
34. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351(25):2599-2610. (Pubitemid 39628581)
35. Lee CC, Adler AI, Sandhu MS, et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia. 2009;52(6):1040-1047.
36. Hu G, Jousilahti P, Tuomilehto J, et al. Association of serum C-reactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. J Clin Endocrinol Metab. 2009;94(6):2099-2105.
37. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med. 1999;106(5):574-582. (Pubitemid 29231110)
38. Johnson JR, Lacey JV Jr, Lazovich D, et al. Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(1):196-203.
39. Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. J Natl Cancer Inst. 2005;97(12): 906-916. (Pubitemid 41417942)
40. Santarelli R, Pierre F, Corpet D. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008;60(2):131-144.
41. Nettleton JA, Steffen LM, Mayer-Davis EJ. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2006;83(6):1369-1379.
42. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003;108(2):155-160.
43. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev. 1994;10(2):91-117.
44. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science. 1978; 200(4337):21-27.